-
1
-
-
0034916930
-
The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
-
Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy; 2001; 20: 9-14.
-
(2001)
Hypertens Pregnancy
, vol.20
, pp. 9-14
-
-
Brown, M.A.1
Lindheimer, M.D.2
de Swiet, M.3
van Assche, A.4
Moutquin, J.M.5
-
2
-
-
0033084667
-
A review of HELLP syndrome
-
Curtin WM, Weinstein L. A review of HELLP syndrome. J Perinatol; 1999; 19: 138-143.
-
(1999)
J Perinatol
, vol.19
, pp. 138-143
-
-
Curtin, W.M.1
Weinstein, L.2
-
3
-
-
2442439357
-
Eclampsia and pre-eclampsia:A health problem for 2000 years
-
Cricthley H, Maclean AB, Poston,Walker JJ, eds, London: RCOG Press
-
Villar K, Say L, Gulmezoglu AM, Merialdi M, Lindheimer MD, Betran AP, Piaggio G. Eclampsia and pre-eclampsia:a health problem for 2000 years. In: Cricthley H, Maclean AB, Poston,Walker JJ, eds. Preeclampsia. London: RCOG Press; 2003: 189-207.
-
(2003)
Preeclampsia
, pp. 189-207
-
-
Villar, K.1
Say, L.2
Gulmezoglu, A.M.3
Merialdi, M.4
Lindheimer, M.D.5
Betran, A.P.6
Piaggio, G.7
-
4
-
-
7944221213
-
The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia
-
Manten GT, van der Hoek YY, Marko Sikkema J, Voorbij HA, Hameeteman TM, Visser GH, Franx A. The role of lipoprotein (a) in pregnancies complicated by pre-eclampsia. Med Hypotheses; 2005: 64: 162-169.
-
(2005)
Med Hypotheses
, vol.64
, pp. 162-169
-
-
Manten, G.T.1
van der Hoek, Y.Y.2
Marko, S.J.3
Voorbij, H.A.4
Hameeteman, T.M.5
Visser, G.H.6
Franx, A.7
-
5
-
-
0030001168
-
Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia
-
Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia. Br J Obstet Gynaecol; 1996; 103: 614-620.
-
(1996)
Br J Obstet Gynaecol
, vol.103
, pp. 614-620
-
-
Sattar, N.1
Gaw, A.2
Packard, C.J.3
Greer, I.A.4
-
6
-
-
0031753094
-
Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increase
-
Hubel CA, Shakir Y, Gallaher MJ, McLaughling MK, Roberts JM. Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increase. J Soc Gynecol Invest; 1998: 5: 244-250.
-
(1998)
J Soc Gynecol Invest
, vol.5
, pp. 244-250
-
-
Hubel, C.A.1
Shakir, Y.2
Gallaher, M.J.3
McLaughling, M.K.4
Roberts, J.M.5
-
7
-
-
0024375899
-
Serum levels of apolipoprotein A-1, A-II and HDL cholesterol in second half of normal pregnancy and in pregnancy complicated by preeclampsia
-
Rosing U, Samsioe G, Olund A, Johansson B, Kallner A. Serum levels of apolipoprotein A-1, A-II and HDL cholesterol in second half of normal pregnancy and in pregnancy complicated by preeclampsia. Horm Metab Res; 1989; 21: 376-382.
-
(1989)
Horm Metab Res
, vol.21
, pp. 376-382
-
-
Rosing, U.1
Samsioe, G.2
Olund, A.3
Johansson, B.4
Kallner, A.5
-
8
-
-
0029964365
-
Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum
-
Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ, Roberts JM. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol; 1996; 174: 975-982.
-
(1996)
Am J Obstet Gynecol
, vol.174
, pp. 975-982
-
-
Hubel, C.A.1
McLaughlin, M.K.2
Evans, R.W.3
Hauth, B.A.4
Sims, C.J.5
Roberts, J.M.6
-
9
-
-
0034035642
-
Lipoprotein particles in preeclampsia: Susceptibility to oxidative modification
-
Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Fukaya T. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstet Gynecol; 2000; 96: 55-59.
-
(2000)
Obstet Gynecol
, vol.96
, pp. 55-59
-
-
Wakatsuki, A.1
Ikenoue, N.2
Okatani, Y.3
Shinohara, K.4
Fukaya, T.5
-
10
-
-
0002557986
-
Human serum paraoxonase/arylesterase
-
W. Kalow, editor. Pergamon Press, New York
-
La Du B. Human serum paraoxonase/arylesterase. Pharmacogenetics of Drug Metabolism. W. Kalow, editor. Pergamon Press, New York.; 1992: 51: 191.
-
(1992)
Pharmacogenetics of Drug Metabolism
, vol.51
, pp. 191
-
-
la Du, B.1
-
13
-
-
0031696245
-
Paraoxonase and coronary heart disease
-
Mackness B, Durrington P N, Fogelman AM, Berliner J, Lusis AJ, Navab M, Shih D, Fonarow GC. Paraoxonase and coronary heart disease. Curr Opin Lipidol; 1998; 9: 319-324.
-
(1998)
Curr Opin Lipidol
, vol.9
, pp. 319-324
-
-
Mackness, B.1
Durrington, P.N.2
Fogelman, A.M.3
Berliner, J.4
Lusis, A.J.5
Navab, M.6
Shih, D.7
Fonarow, G.C.8
-
14
-
-
0032971881
-
Paraoxonase genes and disease
-
Hegele R. Paraoxonase genes and disease. Ann Med; 1999; 31: 217-224.
-
(1999)
Ann Med
, vol.31
, pp. 217-224
-
-
Hegele, R.1
-
15
-
-
0029020612
-
HDL, its enzymes and its potential to influence lipid peroxidation
-
Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis; 1995; 115: 243-253.
-
(1995)
Atherosclerosis
, vol.115
, pp. 243-253
-
-
Mackness, M.I.1
Durrington, P.N.2
-
17
-
-
17644440637
-
Human serum paraoxonase is inhibited in EDTA plasma
-
Mackness M. Human serum paraoxonase is inhibited in EDTA plasma. Biochem Biophys Res Commun; 1998; 242: 249.
-
(1998)
Biochem Biophys Res Commun
, vol.242
, pp. 249
-
-
Mackness, M.1
-
18
-
-
17344369784
-
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R
-
Aviram M, Billecke S, Sorenson R, Bisgaier C, Newton R, Rosenblat M, Erogul J, Hsu C, Dunlop C, La Du B. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler Thromb Vasc Biol; 1998; 18: 1617-1624.
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1617-1624
-
-
Aviram, M.1
Billecke, S.2
Sorenson, R.3
Bisgaier, C.4
Newton, R.5
Rosenblat, M.6
Erogul, J.7
Hsu, C.8
Dunlop, C.9
la Du, B.10
-
19
-
-
0032945537
-
Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the QR genetic polymorphism
-
Cao H, Girard-Globa A, Berthezene F, Moulin P. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the QR genetic polymorphism. J Lipid Res; 1999; 40: 133-139.
-
(1999)
J Lipid Res
, vol.40
, pp. 133-139
-
-
Cao, H.1
Girard-Globa, A.2
Berthezene, F.3
Moulin, P.4
-
20
-
-
0035185259
-
Pregnancy complicated by pre-eclampsiaeclampsia with HELLP syndrome
-
Vigil De Gracia P. Pregnancy complicated by pre-eclampsiaeclampsia with HELLP syndrome. Int J Gynaecol Obstet. 2001; 72(1): 17-23.
-
(2001)
Int J Gynaecol Obstet
, vol.72
, Issue.1
, pp. 17-23
-
-
de Gracia, V.P.1
-
21
-
-
0034995515
-
Serum paraoxonase activities in hemodialyzed uremic patients: Cohort study
-
Juretic D, Tadijanovic M, Rekic B, Simeon-Rudolf V, Reiner E, Baricic M. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J; 2001; 42: 146-150.
-
(2001)
Croat Med J
, vol.42
, pp. 146-150
-
-
Juretic, D.1
Tadijanovic, M.2
Rekic, B.3
Simeon-Rudolf, V.4
Reiner, E.5
Baricic, M.6
-
22
-
-
10644280741
-
Measurement of the total antioxidant response in preeclampsia with a novel automated method
-
Harma MI, Harma M, Erel O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol; 2005; 118: 47-51.
-
(2005)
Eur J Obstet Gynecol Reprod Biol
, vol.118
, pp. 47-51
-
-
Harma, M.I.1
Harma, M.2
Erel, O.3
-
23
-
-
23444431852
-
Preeclampsia and serum antibodies to oxidised low-density lipoprotein
-
Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet; 1994; 343: 645-646.
-
(1994)
Lancet
, vol.343
, pp. 645-646
-
-
Branch, D.W.1
Mitchell, M.D.2
Miller, E.3
Palinski, W.4
Witztum, J.L.5
-
24
-
-
0031712585
-
Antibodies against copper oxidised and malondialdehydemodified low density lipoproteins in pre-eclampsia pregnancies
-
Uotila J, Solakivi T, Jaakkola O, Tuimala R, Lehtimaki T. Antibodies against copper oxidised and malondialdehydemodified low density lipoproteins in pre-eclampsia pregnancies. Br J Obstet Gynaecol; 1998; 105: 1113-1117.
-
(1998)
Br J Obstet Gynaecol
, vol.105
, pp. 1113-1117
-
-
Uotila, J.1
Solakivi, T.2
Jaakkola, O.3
Tuimala, R.4
Lehtimaki, T.5
-
25
-
-
2442428263
-
Changes of serum paraoxonase (HDL cholesterol associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women
-
Kumru S, Aydin S, Gursu MF, Ozcan Z. Changes of serum paraoxonase (HDL cholesterol associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol; 2004; 114: 177-181.
-
(2004)
Eur J Obstet Gynecol Reprod Biol
, vol.114
, pp. 177-181
-
-
Kumru, S.1
Aydin, S.2
Gursu, M.F.3
Ozcan, Z.4
-
26
-
-
0036238751
-
Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies
-
Belo L, Caslake M, Gaffney D, Santos-Silva A, Pereira-Leite L, Quntanilha H, Rebelo I. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis; 2002; 162: 425-432.
-
(2002)
Atherosclerosis
, vol.162
, pp. 425-432
-
-
Belo, L.1
Caslake, M.2
Gaffney, D.3
Santos-Silva, A.4
Pereira-Leite, L.5
Quntanilha, H.6
Rebelo, I.7
-
27
-
-
0031106510
-
Lipoprotein subfraction concentrations in preeclampsia: Pathogenic parallels to atherosclerosis
-
Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997; 89(3): 403-408.
-
(1997)
Obstet Gynecol
, vol.89
, Issue.3
, pp. 403-408
-
-
Sattar, N.1
Bendomir, A.2
Berry, C.3
Shepherd, J.4
Greer, I.A.5
Packard, C.J.6
-
28
-
-
0032750625
-
Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women
-
Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int J Gynaecol Obstet. 1999; 67(3): 147-155.
-
(1999)
Int J Gynaecol Obstet
, vol.67
, Issue.3
, pp. 147-155
-
-
Ware-Jauregui, S.1
Sanchez, S.E.2
Zhang, C.3
Laraburre, G.4
King, I.B.5
Williams, M.A.6
-
29
-
-
77449112551
-
Association of midgestational paraoxonase 1 activity with pregnancies complicated by preeclampsia
-
Baker AM, Klein RL, Haeri S, Moss KL, Boggess KA. Association of midgestational paraoxonase 1 activity with pregnancies complicated by preeclampsia. Am J Perinatol. 2010; 27(3): 205-210.
-
(2010)
Am J Perinatol
, vol.27
, Issue.3
, pp. 205-210
-
-
Baker, A.M.1
Klein, R.L.2
Haeri, S.3
Moss, K.L.4
Boggess, K.A.5
-
30
-
-
34250697416
-
Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia
-
Kim YJ, Park H, Lee HY, Ahn YM, Ha EH, Suh SH, Pang MG. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2007; 133(1): 47-52.
-
(2007)
Eur J Obstet Gynecol Reprod Biol
, vol.133
, Issue.1
, pp. 47-52
-
-
Kim, Y.J.1
Park, H.2
Lee, H.Y.3
Ahn, Y.M.4
Ha, E.H.5
Suh, S.H.6
Pang, M.G.7
|